Duligotuzumab Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Duligotuzumab stocks.

Duligotuzumab Stocks Recent News

Date Stock Title
Duligotuzumab

Duligotuzumab (INN) is a bispecific humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFR and HER3. It is in development by Roche. Clinical development for head and neck cancer and colorectal cancer have been discontinued, but phase I trials in combination with cobimetinib are evaluating safety for treatment of solid tumors.

Browse All Tags